ArticleJournal of otology2026
Neurobrucellosis: An Uncommon but Important Cause of Sensorineural Hearing Loss: a case report.
Article in Journal of otology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Brucellosis is a zoonotic infection common in Mediterranean countries and the Middle East. Neurological involvement, although rare, can lead to severe complications, including sensorineural hearing loss (SNHL). This case is particularly noteworthy as it highlights irreversible auditory nerve damage in brucellosis, emphasizing the importance of early diagnosis and treatment to prevent permanent neurological consequences. The novelty of this case lies in the severity of auditory involvement despite timely treatment. Case Presentation: A 43-year-old male farmer of Maghrebi origin presented with neurobrucellosis complicated by severe, irreversible bilateral sensorineural hearing loss. The patient initially reported symptoms of hearing loss and dizziness, which were confirmed to be associated with auditory nerve involvement. Wright's serology and polymerase chain reaction (PCR) testing confirmed brucellosis. Despite appropriate and prolonged antibiotic therapy, including drugs that penetrate the meningeal barrier and act intracellularly, the patient's auditory impairment remained permanent. The patient is currently a candidate for cochlear implantation to manage his severe hearing loss. Neurological symptoms did not improve with treatment, but cochlear implantation may offer a potential solution to his hearing deficit. Conclusions: This case highlights the importance of early recognition and intervention in brucellosis cases, particularly those with neurological involvement. Delayed diagnosis and treatment can result in irreversible neurological damage. It also underscores the potential for cochlear implantation in patients with severe, irreversible sensorineural hearing loss caused by neurobrucellosis. Cochlear implantation offers an important solution for patients with brucellosis-related hearing deficits, improving their quality of life despite the neurological damage caused by the infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.